Bring just to a boil and stir in the oats
The Takeaway Properly used injections are an effective treatment for growth hormone deficiency
Gastrointestinal adverse reactions, including diarrhea, were the most common reason for treatment discontinuation in clinical trials, with approximately 4-7% of patients discontinuing due to GI events
Some patients reach their health and weight loss goals on medication alone and stay on it long-term
Important safety considerations: Seek urgent same-day medical assessment via NHS 111 or A&E for severe abdominal pain (potential pancreatitis) and stop taking the medication pending review Report persistent nausea, vomiting, or signs of dehydration Be aware of increased hypoglycaemia risk if taking insulin or sulfonylureas (dose adjustments may be needed) Attend regular monitoring appointments for kidney function, diabetic retinopathy, and other parameters Discuss contraception if you are of childbearing potential, as GLP-1 receptor agonists are generally not recommended during pregnancy or breastfeeding [11] Report any suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) Specific administration requirements vary by product
hyperglycemia acts directly on glomerular podocytes to increase their permeability to albumin [85, 86], and its correction should reduce urinary protein excretion
